|
|
Shengtai Pharma’s Second Quarter Disappoints
publication date: Feb 13, 2009
Shengtai Pharmaceutical, Inc. reported disappointing results for its Q2, which ended December 31, 2008. The company recorded $14.8 million in revenue, a drop of 41%, because of a large decline in sales of its cornstarch business. Sales of its other major product, pharmaceutical grade glucose, actually climbed 13% to $9.3 million. More details... Stock Symbol: (OTCBB: SGTI)
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Other Events
China Pharmaceutical R&D SummitApril 23-26, 2012 Shanghai, China Biosimilars Asia 2012April 23-26, 2012 Shanghai, China Vaccines China 2012April 23-26, 2012 Shanghai, China
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|